Skip to main content
Loading

Speed, diversity, modalities: Future frontiers in LI/LO

14 Apr 2025
Lead Identification & Optimization
  • Lead generation as a commodity? What challenges remain
  • Diversity and ML-based selections:  Never do LO again?
  • Smaller modalities (sdAbs, miniproteins, peptides) -  Complementary or competition?
  • What are break-through technologies to watch?
Industry Expert
Lore Florin, Senior Director, Discovery Platforms - AstraZeneca